COVID-19 and tuberculosis-threats and opportunities.
暂无分享,去创建一个
D. Hui | G. Ippolito | Alimuddin Zumla | N. Kapata | F. Ntoumi | T. McHugh | E. Petersen | Simon Tiberi | P. Chanda-Kapata | M. Maeurer | C. Leung | G. Migliori | R. Centis | B. Marais | S. Mfinanga | D. Cirillo
[1] T. Lam,et al. Mask wearing to complement social distancing and save lives during COVID-19. , 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[2] A. Spanevello,et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases , 2020, European Respiratory Journal.
[3] C. Cordon-Cardo,et al. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies , 2020, International Journal of Infectious Diseases.
[4] A. Spanevello,et al. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts , 2020, Pulmonology.
[5] D. Cirillo,et al. The prospects for the SARS‐CoV‐2 pandemic in Africa , 2020, EMBO Molecular Medicine.
[6] Tai Hing Lam,et al. Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity , 2020, The Lancet.
[7] M. Niederman,et al. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security , 2020, Current opinion in pulmonary medicine.
[8] Tai Hing Lam,et al. Mass masking in the COVID-19 epidemic: people need guidance , 2020, The Lancet.
[9] G. Ippolito,et al. Host-directed therapies and holistic care for tuberculosis. , 2020, The Lancet. Respiratory medicine.
[10] Alimuddin Zumla,et al. Post TB treatment infectious complications. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[11] D. Hui,et al. Emerging and Reemerging Infectious Diseases: Global Overview , 2019, Infectious Disease Clinics of North America.
[12] T. Sorrell,et al. Advancing Planetary Health in Australia: focus on emerging infections and antimicrobial resistance , 2019, BMJ Global Health.
[13] S. Hoffman,et al. Delays in Global Disease Outbreak Responses: Lessons from H1N1, Ebola, and Zika , 2018, American journal of public health.
[14] S. Galwankar,et al. The Forgotten Plague: Psychiatric Manifestations of Ebola, Zika, and Emerging Infectious Diseases , 2017, Journal of global infectious diseases.
[15] P. Kaleebu,et al. Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential , 2016, International Journal of Infectious Diseases.
[16] Alimuddin Zumla,et al. Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread , 2014, The Lancet Infectious Diseases.
[17] Z. Memish,et al. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome , 2014, Current opinion in pulmonary medicine.
[18] A. Skrahin,et al. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. , 2014, The Lancet. Respiratory medicine.
[19] S. Nava,et al. Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches , 2020 .